Posted on

Xarelto Lawsuit Filed Over Brain Hemorrhage

Xarelto Lawsuits for the Xarelto Blood Thinner
Xarelto Lawsuits for the Xarelto Blood Thinner

FREE CASE EVALUATION: 1-800-632-1404

Patients using Xarelto blood thinner are at the enhanced risk of brain hemorrhage and the danger assumes grievous propotions in the absence of any effective agent to reverse the drug effects. A Xarelto lawsuit filed in a Louisiana eastern district federal court claims that the plaintiff suffered from serious and life-threatening brain hemorrhage after he was treated with the drug. Manufactured by Bayer and marketed by Janssen, the blood thinner has been cited for causing serious internal bleeding complications.

According to the lawsuit, James J. Brien was prescribed Xarelto in April 2013 following diagnosis of non-valvular atrial fibrillation, a cardiac complication. He was hospitalized following brain hemorrhage in September 2014 and endured a paralysis attack. Though he was discharged after months of recovery and rehab process, the patient suffered from walking disability. The plaintiff took the blood thinner as directed to avert heart strokes, but he ended up in damage to his brain unaware of side effect hazards, his Xarelto attorney claims.

It is unsuspecting for the plaintiff to predict adverse events, such as internal bleeding, while he started taking the drug, as there was no such information by the manufacturer. He came to know about it only after research reports hinted at serious bleeding events and filed a Xarelto lawsuit seeking product liability and recovery of damages.

Xarelto Blood Thinner Hemorrhage Risks

In June 2014, a Xarelto lawsuit filed in a Florida court linked the blood thinner to fatal subdural hemorrhage condition. William Packard died of uncontrollable brain hemorrhage within six months of taking the drug to treat atrial fibrillation. His family has sought $10 million in economic and non-economic damages from the blood thinner manufacturers. It followed many similar claims blaming the medication for cerebral hemorrhage, intracranial bleeding, and gastrointestinal bleeding.

Stroke or rupture in blood vessels spills out the blood into the skull, tissues, and membranes. Patients experience intracranial pressure, irritation, inflammation, swelling, and development of hematoma. As a result the blood-oxygen supply to the brain was prevented and brain cells can die. Such type of cerebral hemorrhage has the potential to cause permanent brain damage and cognitive complications, such as vision loss, seizures, confusion, and coma.

Xarelto attorneys claim that the medication has the ability to “interrupt the intrinsic and extrinsic pathways of the blood coagulation cascade” for 24 hours and it has the potential to worsen patient conditions with excessive, life-threatening bleeding, as there is no medication at present to counter its anticougaltion properties. Due to the drug’s ability to “bind to plasma proteins tightly,” even dialysis proves to be futile to cleanse the body of the medication. In Germany, at least 72 people and 890 had died hemorrhage in 2013 linked to Xarelto internal bleeding.

In 2013, the American Heart Association warned of three-fold greater internal bleeding risk in patients using the blood thinner. The hazard goes up for patients with Acute Coronary Syndrome. Following reports of high-bleeding cost vis-à-vis the drug efficacy, the FDA refused to allow Xarelto as a mode of treatment for those suffering from Acute Coronary Syndrome.

In December 2013, the Journal of the American College of Cardiology cited research findings highlighting that 74% of Xarelto internal bleeding events are intracerebral hemorrhage type.

Possible Xarelto Brain Hemorrhage Injuries

  • Wrongful death
  • Damage to brain
  • Swelling and inflammation of brain
  • Intracranial hematoma in brain
  • Seizures
  • Coma
  • Loss of vision
  • Intracranial pressure

Xarelto Lawsuit

The FDA approved Xarelto blood thinner in 2011 to treat potential risk of blood clotting that can cause heart attack, pulmonary embolism, thrombolic events, and stroke in patients. However, research studies have found that the drug does not offer any significant advantage over other and existing anticoagulants. Additionally, it poses higher risk of frequent brain, stomach, and intestine bleeding that can be life threatening. Xarelto attorneys claim that overpromotion of the drug as superior and suppression of side effects by manufacturers misled their clients to use the blood thinner and suffer from fatal complications.

About 30 Xarelto lawsuits have been filed in 14 states citing “negligence, concealing of information, misrepresentation, and false advertisement” by the manufacturer. If you have a potential claim related to the blood thinner side effects, please contact us or call on 1-800-632-1404 for a free consultation with an Xarelto attorney.

Contact a Xarelto Injury Lawyer Today.

If you or a loved one was injured or died after ingesting Xarelto, please contact us immediately.

For a Free Case Evaluation:

TOLL FREE: 1-800-632-1404

EMAIL: click here

FILL OUT THIS FORM:

    Your Name (required)

    Your Email (required)

    Your Telephone Number

    What year was your child born?

    Where do you live (state)?

    NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

    Posted on

    Xarelto Lawsuit: Plaintiffs Allege Life-Threatening Bleeding Linked to Blood Thinner

    xarelto-injury

    FREE CASE EVALUATION: 1-800-632-1404

    A Xarelto lawsuit filed by an 87-year-old man claims that he experienced life-threatening internal bleeding caused by the blood thinner. The litigation filed in a California northern district federal court in October 2014 cites gastrointestinal hemorrhage as one of the blood thinner side effects. The plaintiff was treated with the anticoagulant drug for some months until October 2014, when he suffered from uncontrolled hemorrhage in the absence of any antidote to the drug, the Xarelto attorney representing the man claims.

    The litigation followed a similar Xarelto internal bleeding lawsuit filed by a California woman in August 2014. Shirley Boynton began using the blood thinner in April 2012. She had life-threatening bleeding within six months that resulted in debilitating and permanent injuries. Had she been aware of such potential side effects or read about hemorrhaging risk on its label, the plaintiff would have avoided it, according to her Xarelto lawsuit filed in a New York district court.

    The two lawsuits have named Bayer and Johnson and Johnson as defendants and seek $10 million in damages.

    Xarelto Lawsuit: Blood Thinner Side Effects Research

    The FDA approved Bayer’s oral anticoagulant Xarelto, which contains rivaroxaban, in July 2011. Marketed by Janssen, the drug is prescribed to people with knee surgery or others at the higher risk of blood clotting. It inhibits factor Xa, which in turn “interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade.” In November 2011, the drug was allowed to treat patients suffering from atrial fibrillation or clots in blood arteries, a possible indication of stroke.

    However, researchers have questioned the efficacy of the drug advertised by the manufacturers. Though the impact is slated to last 8 to 12 hours, the anticougaltion properties in the body continue to remain subdued for 24 hours. The absence of any readily available antidote makes the Xarelto blood thinner even more dangerous and may lead to excessive, life-threatening bleeding, as cited by many product liability lawsuits.

    According to the American Heart Association, Xarelto is likely to cause the three-time higher risk of internal bleeding acute ill patients. The risk is four-time more in those with preexisting Acute Coronary Syndrome, asserts one of its reports presented in November 2013.

    The German newsmagazine Der Spiegel carried a report in 2013 that linked Xarelto blood thinner to 72 deaths and 896 hemorrhage events between January and October 2013. The figures for 2012 were 58 deaths and 692 internal bleeding complaints.

    A comparative study by Johnson & Johnson conducted in April 2011 discovered that patients treated with oral anticoagulant Xarelto for more than 35 days twice more prone to developing bleeding adverse events compared to Lovenox, an injectable blood thinner with enoxaparin as the main ingredient.

    The ROCKET AF clinical trial results reported the Journal of the American College of Cardiology in December 2013 also demonstrated bleeding or hemorrhage as the most common Xarelto side effect. Funded by the manufacturers, the study covered 14,000 patients treated with Xarelto and Warfarin blood thinners over a two-year period. While both drugs were found to cause identical side effects, Xarelto was not superior to Warfarin, the researchers concluded.

    It was also discovered that Xarelto-induced hemorrhage has less impact in the brain, but had significant bleeding rate for stomach and intestine.

    Xarelto Blood Thinner Side Effects

    • Cerebral hemorrhage
    • Gastrointestinal bleeding
    • Stroke
    • Wrongful death
    • Stomach and adrenal bleeding
    • Subarachnoid, subdural, and extradural hemorrhages
    • Swelling leads to intracranial hematoma in brain

    Xarelto Lawsuit

    A motion was filed early October 2014 to centralize all Xarelto hemorrhage lawsuits filed in different states. At that time about two dozen such litigations citing bleeding injuries were pending at the federal judicial system spread over 10 states. The plaintiffs have sought MDL pretrial consolidation at the Southern District Court of Illinois presided by David R. Herndon. The U.S. JPML planned to meet in Charleston, SC, on December 4 or in Miami, FL, on January 29 is expected to take a look at consolidation.

    Meanwhile, there has been a noticeable increase in the filing of Xarelto lawsuits claiming wrongful death, fatal and non-fatal internal bleeding, coma, cerebral hemorrhage, and other types of injuries. The actual litigation numbers may run in hundreds as many affected individuals contacting Xarelto lawyers to examine the product liability claims.

    For a free consultation with our experienced Xarelto attorneys, please contact us or call on 1-800-632-1404.

    Contact a Xarelto Injury Lawyer Today.

    If you or a loved one was injured or died after ingesting Xarelto, please contact us immediately.

    For a Free Case Evaluation:

    TOLL FREE: 1-800-632-1404

    EMAIL: click here

    FILL OUT THIS FORM:

      Your Name (required)

      Your Email (required)

      Your Telephone Number

      What year was your child born?

      Where do you live (state)?

      NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.